Colgate D Goulakos set to begin cancer treatment

Published on NewsOK Modified: January 29, 2013 at 4:23 pm •  Published: January 29, 2013
Advertisement
;

HAMILTON, N.Y. (AP) — Colgate defenseman Spiro Goulakos has Hodgkin's lymphoma and has left the team to begin chemotherapy in his native Montreal.

The disease, a type of cancer originating from white blood cells in the lymph nodes, was detected during a routine exam.

Colgate coach Don Vaughan says the news came "as quite a shock to everyone." Vaughan called the past week a very emotional time for the team.

Goulakos is expected to undergo aggressive chemotherapy, given intravenously, over the next four to six months and is expected to fully recover and be back to full academics and athletics at Colgate in the fall.